Alliancebernstein L.P. Alpine Immune Sciences, Inc. Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.75 - $41.6 $199,687 - $468,000	11,250 Added 37.45%	41,290 $1.64 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $98,551 - $233,338	11,540 Added 62.38%	30,040 $572,000
Q3 2023 Nov 14, 2023	BUY	$10.13 - $13.98 $27,148 - $37,466	2,680 Added 16.94%	18,500 $211,000
Q2 2023 Aug 15, 2023	BUY	$6.84 - $11.91 $108,208 - $188,416	15,820 New	15,820 $162,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.